Daily Traders Edge

Pfizer weighs sale of consumer healthcare business

October 10
12:59 2017

Pfizer weighs sale of consumer healthcare businessThe move comes as Germany’s Merck KGaA (MRCG.DE) is also looking to divest its non-prescription products, including brands such as Seven Seas vitamins, which could be worth around $4.5 billion. As ageing populations and health-conscious consumers drive demand for self-medication, the fragmented consumer health sector has proved a fertile ground for deal-making in recent years. Pfizer’s consumer healthcare business, whose brands include painkiller Advil and lip balm Chapstick, had revenue of about $3.4 billion in 2016.

Related Articles

Newsletter Signup

Sign up for our free newsletter